Clinical Trials Directory

Trials / Completed

CompletedNCT03851692

Intravenous Cannulation In Children During Sevoflurane Induction

Intravenous Cannulation In Children During Sevoflurane Induction: Which Time is Adequate

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
University Hospital Fattouma Bourguiba · Academic / Other
Sex
All
Age
1 Year – 12 Years
Healthy volunteers
Not accepted

Summary

The early placement of an intravenous (iv) line in children anesthetized with halothane has been shown safe and acceptable compared with later placement. However, there's not well known with sevoflurane use (2). The aim of the investigator's study is to determine whether one should make iv attempts during the early induction period (at 60seconds) or lately (90 or 120 s) and waiting until the child receives additional sevoflurane inhalation anesthesia

Detailed description

the investigators conducted a prospective randomized study, after obtaining Institutional review board approval, which didn't require written parental consent. Children age 1-12 years, undergoing elective general anesthesia via an inhalation induction were randomized to one of three groups of 30 patients each one, for iv placement, either 60s (group E), 90 or 120 s (group L) following loss of lid reflex. Movement on iv placement and incidence of laryngospasm were determined. Difficulty with iv placement was also recorded. Statistical analysis included contingency testing, ANOVA, and non parametric testing. A P-value \<0.05 was considered significant.

Conditions

Interventions

TypeNameDescription
OTHERIntravenous Cannulation (iv placement)The aim of our study is to determine whether one should make intravenous attempts placement during the early induction period (at 60seconds) or lately (90 or 120 s) and waiting until the child receives additional sevoflurane inhalation anesthesia.

Timeline

Start date
2016-08-01
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2019-02-22
Last updated
2019-02-22

Source: ClinicalTrials.gov record NCT03851692. Inclusion in this directory is not an endorsement.